Kewaunee Scientific Corpo... (KEQU)
Kewaunee Scientific Statistics
Share Statistics
Kewaunee Scientific has 2.85M shares outstanding. The number of shares has increased by -0.72% in one year.
| Shares Outstanding | 2.85M |
| Shares Change (YoY) | -0.72% |
| Shares Change (QoQ) | -0.6% |
| Owned by Institutions (%) | 42.94% |
| Shares Floating | 2.11M |
| Failed to Deliver (FTD) Shares | 178 |
| FTD / Avg. Volume | 0.7% |
Short Selling Information
The latest short interest is 55.03K, so 1.93% of the outstanding shares have been sold short.
| Short Interest | 55.03K |
| Short % of Shares Out | 1.93% |
| Short % of Float | 2.49% |
| Short Ratio (days to cover) | 1.48 |
Valuation Ratios
The PE ratio is 5.48 and the forward PE ratio is 21.97. Kewaunee Scientific's PEG ratio is 0.
| PE Ratio | 5.48 |
| Forward PE | 21.97 |
| PS Ratio | 0.5 |
| Forward PS | 0.6 |
| PB Ratio | 1.88 |
| P/FCF Ratio | 6.77 |
| PEG Ratio | 0 |
Enterprise Valuation
Kewaunee Scientific has an Enterprise Value (EV) of 90.52M.
| EV / Sales | 0.44 |
| EV / EBITDA | 5.02 |
| EV / EBIT | 4.63 |
| EV / FCF | 5.96 |
Financial Position
The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.2.
| Current Ratio | 2.37 |
| Quick Ratio | 1.87 |
| Debt / Equity | 0.2 |
| Debt / EBITDA | 0.61 |
| Debt / FCF | 0.72 |
| Interest Coverage | 10.16 |
Financial Efficiency
Return on Equity is 34.25% and Return on Invested Capital is 26.74%.
| Return on Equity | 34.25% |
| Return on Assets | 13.92% |
| Return on Invested Capital | 26.74% |
| Revenue Per Employee | $202.54K |
| Profits Per Employee | $18.64K |
| Employee Count | 1,006 |
| Asset Turnover | 1.51 |
| Inventory Turnover | 7.34 |
Taxes
| Income Tax | -5.94M |
| Effective Tax Rate | -45.26% |
Stock Price Statistics
The stock price has increased by -5.59% in the last 52 weeks. The beta is 0.6, so Kewaunee Scientific's price volatility has been higher than the market average.
| Beta | 0.6 |
| 52-Week Price Change | -5.59% |
| 50-Day Moving Average | 45.69 |
| 200-Day Moving Average | 46.68 |
| Relative Strength Index (RSI) | 38.88 |
| Average Volume (20 Days) | 25.38K |
Income Statement
In the last 12 months, Kewaunee Scientific had revenue of 203.75M and earned 18.75M in profits. Earnings per share was 6.51.
| Revenue | 203.75M |
| Gross Profit | 52.05M |
| Operating Income | 18.28M |
| Net Income | 18.75M |
| EBITDA | 18.04M |
| EBIT | 14.92M |
| Earnings Per Share (EPS) | 6.51 |
Balance Sheet
The company has 23.27M in cash and 11M in debt, giving a net cash position of 12.27M.
| Cash & Cash Equivalents | 23.27M |
| Total Debt | 11M |
| Net Cash | 12.27M |
| Retained Earnings | 47.51M |
| Total Assets | 189.15M |
| Working Capital | 58.44M |
Cash Flow
In the last 12 months, operating cash flow was 19.56M and capital expenditures -4.37M, giving a free cash flow of 15.19M.
| Operating Cash Flow | 19.56M |
| Capital Expenditures | -4.37M |
| Free Cash Flow | 15.19M |
| FCF Per Share | 5.28 |
Margins
Gross margin is 25.55%, with operating and profit margins of 8.97% and 9.2%.
| Gross Margin | 25.55% |
| Operating Margin | 8.97% |
| Pretax Margin | 6.44% |
| Profit Margin | 9.2% |
| EBITDA Margin | 8.86% |
| EBIT Margin | 8.97% |
| FCF Margin | 7.46% |
Dividends & Yields
KEQU pays an annual dividend of $0.95, which amounts to a dividend yield of 4.89%.
| Dividend Per Share | $0.95 |
| Dividend Yield | 4.89% |
| Dividend Growth (YoY) | 11.76% |
| Payout Ratio | 15.99% |
| Earnings Yield | 18.25% |
| FCF Yield | 14.78% |
Analyst Forecast
Currently there are no analyst rating for KEQU.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Jan 7, 1985. It was a forward split with a ratio of 3:2.
| Last Split Date | Jan 7, 1985 |
| Split Type | forward |
| Split Ratio | 3:2 |
Scores
| Altman Z-Score | 2.56 |
| Piotroski F-Score | 5 |